Literature DB >> 19766235

Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor.

An L Moens1, Jordan S Leyton-Mange, Xiaolin Niu, Ronghua Yang, Oscar Cingolani, Elisabeth K Arkenbout, Hunter C Champion, Djahida Bedja, Kathleen L Gabrielson, Juan Chen, Yong Xia, Ashley B Hale, Keith M Channon, Marc K Halushka, Norman Barker, Floris L Wuyts, Pawel M Kaminski, Michael S Wolin, David A Kass, Lili A Barouch.   

Abstract

Stimulation of the beta-adrenergic system is important in the pathological response to sustained cardiac stress, forming the rationale for the use of beta-blockers in heart failure. The beta3-adrenoreceptor (AR) is thought to couple to the inhibitory G-protein, G(i), with downstream signaling through nitric oxide, although its role in the heart remains controversial. In this study, we tested whether lack of beta3-AR influences the myocardial response to pressure-overload. Baseline echocardiography in mice lacking beta3-AR (beta3(-/-)) compared to wild type (WT) showed mild LV hypertrophy at 8 weeks that worsened as they aged. beta3(-/-) mice had much greater mortality after transverse aortic constriction (TAC) than WT controls. By 3 weeks of TAC, systolic function was worse. After 9 weeks of TAC, beta3(-/-) mice also had greater LV dilation, myocyte hypertrophy and enhanced fibrosis. NOS activity declined in beta3(-/-)TAC hearts after 9 weeks, and total and NOS-dependent superoxide rose, indicating heightened oxidative stress and NOS uncoupling. The level of eNOS phosphorylation in beta3(-/-)TAC hearts was diminished, and nNOS and iNOS expression levels were increased. GTP cyclohydrolase-1 expression was reduced, although total BH4 levels were not depleted. 3 weeks of BH4 treatment rescued beta3(-/-) mice from worsened remodeling after TAC, and lowered NOS-dependent superoxide. Thus, lack of beta3-AR signaling exacerbates cardiac pressure-overload induced remodeling and enhances NOS uncoupling and consequent oxidant stress, all of which can be rescued with exogenous BH4. These data suggest a cardioprotective role for the beta3-AR in modulating oxidative stress and adverse remodeling in the failing heart.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766235      PMCID: PMC2761504          DOI: 10.1016/j.yjmcc.2009.06.005

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  41 in total

1.  Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.

Authors:  S Moniotte; L Kobzik; O Feron; J N Trochu; C Gauthier; J L Balligand
Journal:  Circulation       Date:  2001-03-27       Impact factor: 29.690

2.  beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility.

Authors:  P Varghese; R W Harrison; R A Lofthouse; D Georgakopoulos; D E Berkowitz; J M Hare
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 3.  Potential use of beta(3)-adrenoceptor antagonists in heart failure therapy.

Authors:  Stéphane Moniotte; Jean-Luc Balligand
Journal:  Cardiovasc Drug Rev       Date:  2002

Review 4.  Nitric oxide and cardiac function: ten years after, and continuing.

Authors:  P B Massion; O Feron; C Dessy; J-L Balligand
Journal:  Circ Res       Date:  2003-09-05       Impact factor: 17.367

5.  Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.

Authors:  Lili A Barouch; Robert W Harrison; Michel W Skaf; Gisele O Rosas; Thomas P Cappola; Zoulficar A Kobeissi; Ion A Hobai; Christopher A Lemmon; Arthur L Burnett; Brian O'Rourke; E Rene Rodriguez; Paul L Huang; João A C Lima; Dan E Berkowitz; Joshua M Hare
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

6.  The negative inotropic effect of beta3-adrenoceptor stimulation in the beating guinea pig heart.

Authors:  T Kitamura; K Onishi; K Dohi; T Okinaka; N Isaka; T Nakano
Journal:  J Cardiovasc Pharmacol       Date:  2000-05       Impact factor: 3.105

7.  Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice.

Authors:  Lili A Barouch; Dan E Berkowitz; Robert W Harrison; Christopher P O'Donnell; Joshua M Hare
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

8.  Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats.

Authors:  Thibaud Damy; Philippe Ratajczak; Estelle Robidel; Jennifer K Bendall; Patricia Oliviéro; Jorge Boczkowski; Talin Ebrahimian; Françoise Marotte; Jane-Lise Samuel; Christophe Heymes
Journal:  FASEB J       Date:  2003-08-01       Impact factor: 5.191

9.  Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression.

Authors:  Nicholas J Alp; Shafi Mussa; Jeffrey Khoo; Shijie Cai; Tomasz Guzik; Andrew Jefferson; Nicky Goh; Kirk A Rockett; Keith M Channon
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor.

Authors:  Geneviève Tavernier; Gilles Toumaniantz; Mortéza Erfanian; Marie France Heymann; Karine Laurent; Dominique Langin; Chantal Gauthier
Journal:  Cardiovasc Res       Date:  2003-08-01       Impact factor: 10.787

View more
  40 in total

1.  Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS.

Authors:  Kin Lung Siu; Christopher Lotz; Peipei Ping; Hua Cai
Journal:  J Mol Cell Cardiol       Date:  2014-07-24       Impact factor: 5.000

Review 2.  Nuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signaling.

Authors:  George Vaniotis; Bruce G Allen; Terence E Hébert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-02       Impact factor: 4.733

3.  β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Natasha A Fry; Elisha J Hamilton; Gemma A Figtree; Helge H Rasmussen
Journal:  Am J Physiol Cell Physiol       Date:  2015-06-10       Impact factor: 4.249

Review 4.  Rodent models of heart failure: an updated review.

Authors:  A C Gomes; I Falcão-Pires; A L Pires; C Brás-Silva; A F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

5.  Cytosolic H2O2 mediates hypertrophy, apoptosis, and decreased SERCA activity in mice with chronic hemodynamic overload.

Authors:  Fuzhong Qin; Deborah A Siwik; David R Pimentel; Robert J Morgan; Andreia Biolo; Vivian H Tu; Y James Kang; Richard A Cohen; Wilson S Colucci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-14       Impact factor: 4.733

6.  Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase.

Authors:  Xiaolin Niu; Vabren L Watts; Oscar H Cingolani; Vidhya Sivakumaran; Jordan S Leyton-Mange; Carla L Ellis; Karen L Miller; Konrad Vandegaer; Djahida Bedja; Kathleen L Gabrielson; Nazareno Paolocci; David A Kass; Lili A Barouch
Journal:  J Am Coll Cardiol       Date:  2012-05-29       Impact factor: 24.094

Review 7.  Role of estrogen in diastolic dysfunction.

Authors:  Zhuo Zhao; Hao Wang; Jewell A Jessup; Sarah H Lindsey; Mark C Chappell; Leanne Groban
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

8.  Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure.

Authors:  Elena N Dedkova; Lea K Seidlmayer; Lothar A Blatter
Journal:  J Mol Cell Cardiol       Date:  2013-02-04       Impact factor: 5.000

9.  Beneficial cardiac effects of caloric restriction are lost with age in a murine model of obesity.

Authors:  Majd AlGhatrif; Vabren L Watts; Xiaolin Niu; Marc Halushka; Karen L Miller; Konrad Vandegaer; Djahida Bedja; Karen Fox-Talbot; Alicja Bielawska; Kathleen L Gabrielson; Lili A Barouch
Journal:  J Cardiovasc Transl Res       Date:  2013-03-02       Impact factor: 4.132

Review 10.  A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling.

Authors:  Jihong Yang; Yufeng Liu; Xiaohui Fan; Zheng Li; Yiyu Cheng
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.